Reg FD Disclosure · Company Update

CalciMedica, Inc. announced the discontinuation of its Phase 2 KOURAGE clinical trial for Auxora TM in patients with Stage 2 or Stage 3 acute kidney injury with associated acute hypoxemic respiratory failure. This decision was made following a recommendation from the trial’s Independent Data Monitoring Committee due to a safety concern.